Literature DB >> 32873917

Animal models of benign prostatic hyperplasia.

Junjie Zhang1,2, Mengda Zhang1,2, Jin Tang1, Guangming Yin1, Zhi Long1, Leye He1, Chuanchi Zhou1,2, Lufeng Luo1,2, Lin Qi2, Long Wang3.   

Abstract

Benign prostatic hyperplasia (BPH) and associated lower urinary tract symptoms are common clinical concerns that affect aging men all over the world. The underlying molecular and cellular mechanisms remain elusive. Over the past few years, a number of animal models of BPH, including spontaneous model, BPH-induction model, xenograft model, metabolic syndrome model, mechanical obstruction model, and transgenic model, have been established that may provide useful tools to fill these critical knowledge gaps. In this review, we therefore outlined the present status quo for animal models of BPH, comparing the pros and cons with respect to their ability to mimic the etiological, histological, and clinical hallmarks of BPH and discussed their applicability for future research.

Entities:  

Year:  2020        PMID: 32873917     DOI: 10.1038/s41391-020-00277-1

Source DB:  PubMed          Journal:  Prostate Cancer Prostatic Dis        ISSN: 1365-7852            Impact factor:   5.554


  73 in total

Review 1.  Mesenchymal stem cells and the embryonic reawakening theory of BPH.

Authors:  W Nathaniel Brennen; John T Isaacs
Journal:  Nat Rev Urol       Date:  2018-11       Impact factor: 14.432

Review 2.  Androgens and estrogens in benign prostatic hyperplasia: past, present and future.

Authors:  Tristan M Nicholson; William A Ricke
Journal:  Differentiation       Date:  2011-05-26       Impact factor: 3.880

Review 3.  Lower urinary tract symptoms, benign prostatic hyperplasia and metabolic syndrome.

Authors:  Linda Vignozzi; Mauro Gacci; Mario Maggi
Journal:  Nat Rev Urol       Date:  2016-01-12       Impact factor: 14.432

Review 4.  Pathophysiology of Benign Prostatic Hyperplasia and Benign Prostatic Enlargement: A Mini-Review.

Authors:  Stephan Madersbacher; Natalie Sampson; Zoran Culig
Journal:  Gerontology       Date:  2019-04-03       Impact factor: 5.140

5.  The effect of nafarelin acetate, a luteinizing-hormone-releasing hormone agonist, on benign prostatic hyperplasia.

Authors:  C A Peters; P C Walsh
Journal:  N Engl J Med       Date:  1987-09-03       Impact factor: 91.245

6.  Holmium laser enucleation of the prostate versus thulium laser enucleation of the prostate for the treatment of large-volume prostates > 80 ml: 18-month follow-up results.

Authors:  Junjie Zhang; Zhenyu Ou; Xiaobo Zhang; Wei He; Ruizhe Wang; Miao Mo; Lingxiao Chen; Ran Xu; Shusuan Jiang; Xiaoyan Peng; Lin Qi; Long Wang
Journal:  World J Urol       Date:  2019-09-09       Impact factor: 4.226

Review 7.  Estrogen and androgen signaling in the pathogenesis of BPH.

Authors:  Clement K M Ho; Fouad K Habib
Journal:  Nat Rev Urol       Date:  2011-01       Impact factor: 14.432

8.  Antagonists of growth hormone-releasing hormone inhibit proliferation induced by inflammation in prostatic epithelial cells.

Authors:  Petra Popovics; Andrew V Schally; Luis Salgueiro; Krisztina Kovacs; Ferenc G Rick
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-25       Impact factor: 11.205

Review 9.  Androgen replacement therapy and prostate safety.

Authors:  Alvaro Morales
Journal:  Eur Urol       Date:  2002-02       Impact factor: 20.096

10.  The development of human benign prostatic hyperplasia with age.

Authors:  S J Berry; D S Coffey; P C Walsh; L L Ewing
Journal:  J Urol       Date:  1984-09       Impact factor: 7.450

View more
  4 in total

1.  Development of Tough Hydrogel Phantoms to Mimic Fibrous Tissue for Focused Ultrasound Therapies.

Authors:  Yashwanth Nanda Kumar; Zorawar Singh; Yak-Nam Wang; George R Schade; Wayne Kreider; Matthew Bruce; Eli Vlaisavljevich; Tatiana D Khokhlova; Adam D Maxwell
Journal:  Ultrasound Med Biol       Date:  2022-06-10       Impact factor: 3.694

Review 2.  Applications of Vertebrate Models in Studying Prostatitis and Inflammation-Associated Prostatic Diseases.

Authors:  Joosje Bleeker; Zhu A Wang
Journal:  Front Mol Biosci       Date:  2022-07-05

3.  Dihydroartemisinin attenuates benign prostatic hyperplasia in rats by inhibiting prostatic epithelial cell proliferation.

Authors:  Bo Zhang; Xiang Chen; Yu Gan; Bing-Sheng Li; Kang-Ning Wang; Yao He
Journal:  Ann Transl Med       Date:  2021-08

4.  The anti-inflammatory properties of the methanolic extract of Cucumis melo Linn. against prostate enlargement in Wistar rats.

Authors:  R S Rajasree; Sibi P Ittiyavirah; Punnoth Poonkuzhi Naseef; Mohamed Saheer Kuruniyan; Muhammed Elayadeth-Meethal; S Sankar
Journal:  Saudi J Biol Sci       Date:  2022-07-25       Impact factor: 4.052

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.